Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-25 @ 12:43 AM
NCT ID:
NCT00380367
Eligibility Criteria:
Inclusion Criteria:
* Healthy Females Age 9 To 15 Years
* Females Not Sexually Active And Not Plan On Becoming Sexually Active During The Study
* No Fevers 24 Hours Prior To The First Injection
Exclusion Criteria:
* Participant Had Received A Prior Vaccination With A HPV Vaccine
* Participant Has Allergies To Vaccine Component Including Aluminum And Yeast
* Participant Has (Human Immunodeficiency Virus) HIV Infection
* Participant Is Immunocompromised
* Participant Received Or Plans To Receive Blood-Derived Product Within 6 Months Prior To The First Injection
* Participant Received Or Plans To Receive Immune Globulin Preparation Within 6 Months To The First Injection
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
9 Years
Maximum Age:
15 Years
Study:
NCT00380367
Study Brief:
Protocol Section:
NCT00380367